In this regard, the downstream consequences of LEPR signalling, namely sustained activation of the PI3K–AKT–mTOR pathway, become all the more important because, among human cancers, PI3KCA is among the most commonly mutated genes and a target of emerging anti-cancer therapeutics7,36. The gene discussed is AKT1; the disease is cancer.